Box 3.
Study | No. of study subjects | COPD patients characteristics | VEP parameters studied | Percentage of patients with VEP abnormalities | VEP parameters affected | Correlations |
---|---|---|---|---|---|---|
Kayacan et al.[7] | 32 COPD subjects (male=30); no controls (Flash VEP was used) | 19/32 had PaO2 < 55mmHg Age=61±8.8 years; smoking packyears= 37.4±28.5 |
|
None | None | None |
Özge et al.[8] | 28 COPD Patients (male = 26) Controls = 20 (Pattern shift VEP was used) | Severe COPD; Age = 59.4±9.4 years; Only 15/21 smokers, pack-years = 30.8±15.5; FEV1 = 1.4+0.5 L |
|
82.1 |
|
VEP abnormalities ** pH, PaO2, PaCO2, FEV1%, FVC |
Our study | COPD patients = 40, all male (None had clinical neurologic deficiency) Healthy volunteers = 40, all male (Pattern shift VEP was used) | Stable COPD patients, Age = 57.25±9.07 All smokers/exsmokers Smoking pack-years = 39.95±20.94 FEV1 = 1.48±0.50 L |
|
57.5 |
|
Latency P100 on right side** FEV1/FVC%, and MMSE score. |
Significant correlations between variables are shown by (**)